Imran Satia, MA MB BChir (Cantab), MRCP, PhD
St. Joseph’s Healthcare and McMaster University, Hamilton, ON

This session will address the current definitions of chronic cough, refractory chronic cough, unexplained chronic cough; the epidemiology of chronic cough in Canada; the basic neurophysiology of chronic cough; the current investigations available for investigating chronic cough; the role of neuromodulators and speech therapy in chronic cough; and aim to develop an awareness of new P2X3 antagonists currently in development.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Define and classify chronic cough;
  • Describe the epidemiology of chronic cough;
  • Know the basic neurophysiology of chronic cough;
  • Apply the step-wise approach to investigate and manage chronic cough;
  • Review the strengths and weaknesses of current guideline recommended treatment; and
  • Know the new purinergic P2X3 antagonists currently under development.

CanMEDS Roles Addressed: Collaborator, Medical Expert, Scholar